Filtros de búsqueda

Lista de obras de

52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants

artículo científico publicado en 2013

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension

artículo científico publicado en 2007

A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups

artículo científico publicado en 2018

A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon

artículo científico publicado en 2006

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

artículo científico publicado en 2005

A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease

artículo científico publicado en 2008

A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients

artículo científico publicado en 2015

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis

artículo científico publicado en 2005

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

artículo científico publicado en 2013

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease

artículo científico publicado en 2007

AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study

artículo científico publicado en 2014

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry

artículo científico publicado en 2019

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.

artículo científico publicado en 2018

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

artículo científico publicado en 2011

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial

artículo científico publicado en 2012

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2011

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

artículo científico publicado en 2012

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE

artículo científico publicado el 23 de febrero de 2011

Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial

artículo científico publicado en 2015

Allogeneic expanded-adipose derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease

scientific article published on 18 August 2020

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease

artículo científico publicado en 2003

Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study

artículo científico publicado en 2015

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2017

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

artículo científico publicado en 2003

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Are inherited thrombotic risk factors associated with fibrostenosis in Crohnʼs disease?

artículo científico publicado en 2011

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

artículo científico publicado en 2014

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

artículo científico publicado en 2020

Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease

artículo científico publicado en 2012

Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up

artículo científico publicado en 2004

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

artículo científico publicado en 2010

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target

artículo científico publicado en 2014

Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial

artículo científico publicado en 2020

Briakinumab for treatment of Crohn's disease: results of a randomized trial

artículo científico publicado en 2015

Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic review

article published in 2018

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease

artículo científico

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.

artículo científico publicado en 2015

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial

artículo científico publicado en 2016

Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic

artículo científico publicado en 2020

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

artículo científico publicado en 2013

Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis

scientific article published on 22 June 2018

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

artículo científico publicado en 2020

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

artículo científico publicado en 2020

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

artículo científico publicado en 2009

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis

artículo científico publicado en 2018

Competition for Clinical Trials in Inflammatory Bowel Diseases

artículo científico publicado en 2019

Complications in Crohn's disease: right-sided ureteric stenosis and hydronephrosis

artículo científico publicado en 2007

Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab

artículo científico publicado en 2019

Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease

artículo científico publicado en 2020

Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2018

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

scientific article published on 18 May 2020

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

artículo científico publicado en 2020

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

artículo científico publicado en 2011

Development and validation of the Nancy histological index for UC.

artículo científico publicado en 2015

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

artículo científico

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement

artículo científico publicado en 2015

Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease.

artículo científico publicado en 2005

Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?

artículo científico publicado en 2003

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

artículo científico publicado en 2011

Effect of IBD medications on COVID-19 outcomes: results from an international registry

artículo científico publicado en 2020

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study

artículo científico publicado en 2017

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

artículo científico publicado en 2017

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis

scientific article published on 23 November 2018

Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-The Authors' response ⬇️

artículo científico publicado el 1 de marzo de 2011

Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials

artículo científico publicado en 2015

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

artículo científico publicado en 2015

End of Induction Patient Reported Outcomes Predict Clinical Remission but not Endoscopic Remission in Crohn's Disease

scientific article published on 27 November 2020

Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection

artículo científico publicado en 2010

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments

artículo científico publicado en 2020

Erratum: Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Respo

article

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

artículo científico publicado en 2016

Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2017

Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics

artículo científico publicado en 2009

Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trial

artículo científico publicado en 2013

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study

artículo científico publicado en 2009

Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis.

artículo científico publicado en 2014

Factors associated with short- and long-term outcomes of therapy for Crohn's disease

artículo científico publicado en 2014

Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1

artículo científico publicado en 2019

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

artículo científico publicado en 2015

Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy

artículo científico publicado en 2016

Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy

artículo científico publicado en 2019

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

artículo científico publicado en 2010

Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.

artículo científico publicado en 2014

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis

artículo científico publicado en 2018

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

artículo científico publicado en 2009

Healthy offspring in parents both receiving thiopurines

artículo científico publicado en 2004

Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma

artículo científico publicado en 2003

IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting

artículo científico publicado en 2011

IBD patients need in health quality of care ECCO consensus

artículo científico publicado en 2008

IL-10RA truncation mutations and Semite populations

scientific article published on 14 September 2010

Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial

scientific article published on 01 August 2020

Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial

scientific article published on 25 May 2020

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection

scientific article published on 09 September 2020

Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism

artículo científico publicado en 2021

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

artículo científico publicado en 2016

Infliximab for induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2005

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.

artículo científico publicado en 2011

Infliximab, azathioprine, or combination therapy for Crohn's disease

article

Infliximab: lack of efficacy on perforating complications in Crohn's disease

artículo científico publicado en 2004

Interleukin 13 and its role in gut defence and inflammation

artículo científico publicado en 2012

Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care ⬇️

artículo científico publicado en 2015

Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply

scientific article published on 01 June 2020

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

artículo científico publicado en 2018

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

artículo científico publicado en 2017

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding

artículo científico publicado en 2010

Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies

scientific article published on 11 April 2011

Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines ⬇️

artículo científico publicado el 18 de abril de 2010

Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry

artículo científico publicado en 2018

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

artículo científico publicado en 2016

Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis

artículo científico publicado en 2020

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

artículo científico publicado en 2013

Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels

artículo científico publicado en 2013

NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease

artículo científico publicado en 2008

Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production

artículo científico publicado en 2003

Optimising monitoring in the management of Crohn's disease: a physician's perspective

artículo científico publicado en 2013

Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease

artículo científico publicado en 2020

Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis

artículo científico publicado en 2018

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

scientific article published on 20 July 2016

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study

artículo científico publicado en 2017

Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme.

artículo científico publicado en 2011

Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis ⬇️

artículo científico

Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative Colitis

scientific article published on 22 January 2020

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

artículo científico publicado en 2018

Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection

artículo científico publicado en 2009

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2010

Public awareness of Crohn's disease and ulcerative colitis: A national survey ⬇️

artículo científico publicado el 26 de febrero de 2009

Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel diseases management

artículo científico publicado en 2020

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

scientific article published on 01 September 2019

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus

artículo científico publicado en 2012

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

artículo científico publicado en 2013

Reply to GASTRO-D-19-02484-Looking for innovative digital solutions to optimize patient recruitment in IBD trials

scientific article published on 29 March 2020

Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease

artículo científico publicado en 2006

Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis

scientific article published on 01 September 2007

Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease

artículo científico publicado en 2012

Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs.

artículo científico publicado en 2016

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis

artículo científico publicado en 2020

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study

artículo científico publicado en 2015

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

artículo científico publicado en 2012

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

artículo científico

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

artículo científico publicado en 2012

Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?

artículo científico publicado en 2015

Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry

artículo científico publicado en 2012

Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice

artículo científico publicado en 2002

Steroid dependency in Crohn's disease

artículo científico publicado en 2002

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids

artículo científico publicado en 2016

Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis

artículo científico publicado en 2017

Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?

artículo científico

Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1

scientific article published on 01 August 2018

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

artículo científico publicado en 2015

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

artículo científico publicado en 2010

The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.

artículo científico publicado en 2007

The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery

artículo científico publicado en 2009

The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.

artículo científico

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

artículo científico publicado en 2009

The value of serologic markers in indeterminate colitis: a prospective follow-up study

artículo científico publicado en 2002

Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques

artículo científico publicado en 2007

Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme function

artículo científico publicado en 2006

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

scientific article published on 08 July 2019

Tissue factor exposing microparticles in inflammatory bowel disease

artículo científico publicado en 2012

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

scientific article published on 10 September 2018

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2017

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

scientific article published on 27 November 2020

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

artículo científico publicado en 2013

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

scientific article published on 09 October 2019

Week 6 Calprotectin Best Predicts Likelihood of Long-Term Endoscopic Healing in Crohn's Disease: A Post-Hoc Analysis of the UNITI/IM-UNITI Trials

scientific article published on 15 September 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda